RQ BIOTECHNOLOGY LIMITED - Profile & Financials

Accounts Submitted 28 Jul 2025

Confirmation Statement Submitted 31 Mar 2025

Net assets £12.09M £3.35M 2024 year on year

Total assets £13.01M £3.55M 2024 year on year

Total Liabilities £914.24K £203.47K 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Scale Space 58 Wood Lane London W12 7RZ United Kingdom

Office ()

London, England, United Kingdom, Europe

Website

rqbiotechnology.com

Credit Report

Discover RQ BIOTECHNOLOGY LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£10.89M

Decreased by £4.93M (-31%)

Net Assets

£12.09M

Decreased by £3.35M (-22%)

Total Liabilities

£914.24k

Decreased by £203.47k (-18%)

Turnover

N/A

Employees

Increased by 1 (+9%)

Debt Ratio

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

3 Allotments 3,389 Shares £1.41m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
2 Dec 2022	GROWTH A SHARES	2,000	£0.2	£0
2 Dec 2022	ORDINARY	1,075	£1.41m	£1k
20 Oct 2021	ORDINARY	314	£0.031	£0

Officers

2 active 4 resigned

Show resigned officers

						Status
Clare Elizabeth Terlouw	Director	British,canadian	England	52	26 Mar 2021	Active
Michael Westby	Director	British	England	59	26 Mar 2021	Active

Shareholders

Shareholders (8)


Rq Biotechnology Holdings Limited	100.0%	11,389	Ordinary	31 Mar 2025
The Chancellor, Masters And Scholars Of The University Of Oxford	0.0%	0	Ordinary	31 Mar 2025
Paul Kellam	0.0%	0	Ordinary	31 Mar 2025

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Lifearc

United Kingdom

Active

Notified 5 Sept 2023

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Rq Biotechnology Holdings Limited

United Kingdom

Active

Notified 8 Apr 2024

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

RQ BIOTECHNOLOGY HOLDINGS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

LIFEARC united kingdom

RQ BIOTECHNOLOGY LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
28 Jul 2025	Accounts	Annual accounts made up to 2025-03-31	View(22 pages)
31 Mar 2025	Confirmation Statement	Confirmation statement made on 2025-03-25 with updates	View(4 pages)
6 Sept 2024	Incorporation	Memorandum Articles	View(12 pages)
25 Jul 2024	Accounts	Annual accounts made up to 2024-03-31	View(22 pages)
5 Jun 2024	Persons With Significant Control	Rq Biotechnology Holdings Limited notified as a person with significant control	View(2 pages)